Does Insurance Cover LipiFlow? Medicare, Costs, and Appeals

In almost all cases, insurance does not cover LipiFlow. Medicare does not pay for it, and most private health plans classify the thermal pulsation procedure as experimental or investigational, which means patients pay the full price themselves. Expect $700 to $1,500 per session, with Health Savings Account or Flexible Spending Account funds as the most common way to soften the cost.1CareCredit. LipiFlow Cost and Financing2University Eye Associates. LipiFlow

Why Private Insurers Deny LipiFlow

Payers have reached a shared conclusion: the clinical evidence does not yet show LipiFlow works better than cheaper existing treatments. Aetna classifies LipiFlow and similar meibomian gland evacuation devices as “experimental, investigational, or unproven” and states the effectiveness of these approaches “has not been established.”3Aetna. Meibomian Gland Dysfunction Treatments Blue Cross Blue Shield of Michigan uses the same label, citing “insufficient evidence to determine that the technology results in an improvement in net health outcomes.”4Blue Cross Blue Shield of Michigan. Thermal Treatment of Dry Eye Syndrome Medical Policy Blue Cross Blue Shield of Massachusetts lists eyelid thermal pulsation as not covered for all commercial and Medicare Advantage members, and that classification is unchanged through its April 2026 policy update.5Blue Cross Blue Shield of Massachusetts. Eyelid Thermal Pulsation for the Treatment of Dry Eye Syndrome Excellus BCBS treats it the same way.6Excellus BCBS. Management of Dry Eye Syndrome and Meibomian Gland Dysfunction

The research insurers point to is consistent. A 2024 Cochrane systematic review of 13 randomized trials covering 1,155 participants concluded the evidence supporting LipiFlow is of “low or very low certainty” and that the device “performs similarly to other commonly used DED treatments.”7Cochrane. LipiFlow for the Treatment of Dry Eye Disease The American Academy of Ophthalmology’s 2024 guidelines classify thermal pulsation as a “second-stage option” and note that “independent, randomized clinical trials have yet to be performed to assess efficacy or superiority of any one of these treatments over another.”4Blue Cross Blue Shield of Michigan. Thermal Treatment of Dry Eye Syndrome Medical Policy Cost reinforces the stance. Dry eye disease is uncomfortable but not generally classified by insurers as vision-threatening, and covering thermal pulsation across the affected population would be an enormous expense when alternatives like warm compresses exist.8The Eye Care Institute. Dry Eye Disease

Medicare Does Not Cover It

Medicare does not cover LipiFlow.9Healthline. Does Medicare Cover Dry Eye Treatment No Medicare Administrative Contractor has issued a Local Coverage Determination for LipiFlow or any other meibomian gland dysfunction treatment, so there is no formal pathway or set of criteria under which the procedure qualifies for reimbursement.10Ophthalmology Times. What Is Happening With LipiFlow Reimbursement

Confusion has come from how the procedure is coded. LipiFlow uses a temporary Category III CPT code, 0207T, rather than a permanent Category I code.11American Academy of Ophthalmology. Billing 0207T After the 21st Century Cures Act took effect in 2019, Medicare Administrative Contractors could no longer issue blanket non-coverage decisions for Category III codes and had to evaluate claims individually.12Review of Ophthalmology. A Review of the 21st Century Cures Act Some contractors then added 0207T to their fee schedules, which a few providers read as a coverage decision. It was not. The schedules only indicated what the payment would be if coverage were granted.10Ophthalmology Times. What Is Happening With LipiFlow Reimbursement National Government Services later removed 0207T and 0563T from its fee schedule entirely to end the confusion, while continuing to deny claims routinely.13Ophthalmology Times. The Latest on MGD Reimbursements: LipiFlow and TearCare Are Still Out-of-Pocket Procedures In the rare instance a claim did pay, the reimbursement often failed to cover even a third of the cost of the single-use activators the procedure requires. If the provider is a Medicare participant, expect to sign an Advance Beneficiary Notice before the procedure, acknowledging that you will likely owe the full charge.

What About the Dry Eye Workup?

LipiFlow is usually preceded by a dry eye evaluation that may include imaging of the meibomian glands with devices such as LipiView or LipiScan. Whether any of that is covered depends on how the provider bills it and which insurer is involved. Some practices fold the testing into a general dry eye evaluation billed under standard Evaluation and Management codes, which medical insurance may pay. Others use CPT code 92285 for external ocular imaging.14Optometry Times. Diagnosing and Treating Dry Eye Technology Several insurers, however, treat the imaging itself as investigational. Blue Cross Blue Shield of Michigan considers LipiView and LipiScan imaging “experimental/investigational” and lists the associated CPT code 0330T as not covered.4Blue Cross Blue Shield of Michigan. Thermal Treatment of Dry Eye Syndrome Medical Policy Many practices charge patients directly for the diagnostic testing after presenting an Advance Beneficiary Notice. Ask the practice ahead of time what will be billed to insurance and what will be billed to you.

What You Will Pay and How to Pay

A single LipiFlow session generally runs $700 to $1,500.1CareCredit. LipiFlow Cost and Financing The American Academy of Ophthalmology cites roughly $1,500 per application.15American Academy of Ophthalmology. LipiFlow Treatment for Dry Eye Pricing varies by practice and by condition severity, and some providers charge less. The Eye Care Institute lists the procedure at $800.8The Eye Care Institute. Dry Eye Disease

Because insurance rarely picks up any of it, patients have a few practical options:

Can You Appeal a Denial?

You can file one, but the odds are poor. The 21st Century Cures Act requires Medicare Administrative Contractors to evaluate individual claims rather than apply blanket denials, and Johnson & Johnson Vision, the LipiFlow manufacturer, has said it will help providers appeal.12Review of Ophthalmology. A Review of the 21st Century Cures Act On the Medicare side, though, there is no Local Coverage Determination, so there are no written medical necessity criteria to argue against or satisfy, and only a handful of claims have ever been covered and paid. On the commercial side, when a plan’s policy explicitly labels the procedure investigational, there is no documented framework for overturning that classification through a medical necessity appeal. No manufacturer is currently pursuing a permanent CPT code or a formal coverage determination.10Ophthalmology Times. What Is Happening With LipiFlow Reimbursement

Other In-Office Dry Eye Treatments Are Not Covered Either

Switching to a different thermal or light-based dry eye treatment generally will not get you coverage. TearCare (CPT code 0563T), iLux, and intense pulsed light therapy such as OptiLight are also typically not covered by insurance or Medicare.13Ophthalmology Times. The Latest on MGD Reimbursements: LipiFlow and TearCare Are Still Out-of-Pocket Procedures IPL has an added issue: because it has long been used as a cosmetic skin treatment, some insurers slot dry eye IPL into their cosmetic exclusions.19Specialty Eye. Is IPL for Dry Eyes Covered by Insurance Until larger, independently funded, properly blinded trials shift the clinical consensus, the reimbursement picture for all of these procedures is unlikely to change.